Glatiramer acetate
Glatiramer acetate has been studied in 2 papers since 2022: 1 observational study in people, 1 in animals; 1 in the past year. The newest paper, Mar 9, 2026: “Glatiramer acetate stimulates phagocytosis and intracellular killing of Escherichia coli by macrophages and microglial cells”.
None of its findings points the other way.
- 1 lab in 1 country
- Funder: Georg-August-Universität Göttingen
- Humans1
- Animals1
What did studies of Glatiramer acetate find?
2Studies of Glatiramer acetate measured 2 outcomes; the most studied are cell killing (cytotoxicity) (1 study) and phagocytosis (1).
Cell killing (cytotoxicity)
upin mouse cells1
1 study
Cell killing (cytotoxicity)
upin mouse cells1
Glatiramer acetate increases cell killing (cytotoxicity) in mouse cells.
“GA also increases the intracellular killing of E. coli.”
Cellsin wild-type macrophages and microglia
Frontiers in immunology
phagocytosis
upin mouse cells1
1 study
phagocytosis
upin mouse cells1
Glatiramer acetate increases phagocytosis in mouse cells.
“GA increased phagocytosis in a concentration- and time-dependent manner of E. coli by macrophages and microglia isolated from wild-type mice.”
Cellsisolated from wild-type mice
Frontiers in immunology